button bars forest bayes pooled summary circles
 
DCR

mEC - 2nd line (L2) metastatic/advanced - esophageal cancer (mEC) mEC - 2nd line (L2)

versus Standard of Care (SoC)
nivolumab alone vs. Standard of Care (SoC) 1 0.36 [0.23; 0.56], 1 RCT, I2=0%
statistically significant harm

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons